Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is associated with immune dysfunction and an increased risk of melanoma. For patients with metastatic melanoma, immunotherapy with checkpoint blocking antibodies is a standard of care. In patients with concomitant CLL and metastatic melanoma, it is not known whethe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother
Principais autores: Smithy, James W., Pianko, Matthew J., Maher, Colleen, Postow, Michael A., Shoushtari, Alexander N., Momtaz, Parisa, Chapman, Paul B., Wolchok, Jedd D., Park, Jae H., Callahan, Margaret K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727280/
https://ncbi.nlm.nih.gov/pubmed/33290361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000345
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados